PHAXIAM Trademark

Trademark Overview


On Wednesday, August 2, 2023, a trademark application was filed for PHAXIAM with the United States Patent and Trademark Office. The USPTO has given the PHAXIAM trademark a serial number of 98114171. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 16, 2024. This trademark is owned by Phaxiam Therapeutics. The PHAXIAM trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Diagnostic substances in the nature of reactants for medical diagnosis; diagnostic substances in the nature of reactants for veterinary diagnosis; bacteria, bacteriophages, viruses, all for medical and veterinary use; phage lysate-based products; lysine preparations

Medical diagnostic apparatus in the nature of tools for testing clinical bacterial strains; Veterinary diagnostic apparatus in the nature of tools for testing clinical bacterial strains; Medical diagnostic and veterinary apparatus in the nature of tools for determining the sensitivity of bacteria to bacteriophages
phaxiam

General Information


Serial Number98114171
Word MarkPHAXIAM
Filing DateWednesday, August 2, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the wording "PHAXIAM" written in a stylized font with the letters "PHAX" and "AM" written in a stylized dark blue font and the letter "i" stylized and in gradient shades of green and blue. The title in the letter "i" is written in green. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Goods and ServicesDiagnostic substances in the nature of reactants for medical diagnosis; diagnostic substances in the nature of reactants for veterinary diagnosis; bacteria, bacteriophages, viruses, all for medical and veterinary use; phage lysate-based products; lysine preparations
Indication of Colors claimedThe color(s) green and blue is/are claimed as a feature of the mark.
Goods and ServicesMedical diagnostic apparatus in the nature of tools for testing clinical bacterial strains; Veterinary diagnostic apparatus in the nature of tools for testing clinical bacterial strains; Medical diagnostic and veterinary apparatus in the nature of tools for determining the sensitivity of bacteria to bacteriophages

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 31, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, August 31, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhaxiam Therapeutics
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLyon 69008
FR

Trademark Events


Event DateEvent Description
Thursday, March 21, 2024ASSIGNED TO LIE
Saturday, August 5, 2023NEW APPLICATION ENTERED
Thursday, August 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 1, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, March 21, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, April 4, 2024NON-FINAL ACTION WRITTEN
Tuesday, April 2, 2024ASSIGNED TO EXAMINER
Thursday, April 4, 2024NON-FINAL ACTION E-MAILED
Thursday, April 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 16, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED